請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42635
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 許秉寧(Ping-Ning Hsu) | |
dc.contributor.author | Wei-Le Wang | en |
dc.contributor.author | 王維樂 | zh_TW |
dc.date.accessioned | 2021-06-15T01:18:20Z | - |
dc.date.available | 2014-09-15 | |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-07-27 | |
dc.identifier.citation | Agrwal, N., Sun, Q., Wang, S.Y., and Wang, J.L. (1993). Carbohydrate-binding protein 35. I. Properties of the recombinant polypeptide and the individuality of the domains. J Biol Chem 268, 14932-14939.
Barondes, S.H., Castronovo, V., Cooper, D.N., Cummings, R.D., Drickamer, K., Feizi, T., Gitt, M.A., Hirabayashi, J., Hughes, C., Kasai, K., et al. (1994). Galectins: a family of animal beta-galactoside-binding lectins. Cell 76, 597-598. Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., Whitesell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F., and Ochs, H.D. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27, 20-21. Beswick, E.J., Pinchuk, I.V., Das, S., Powell, D.W., and Reyes, V.E. (2007). Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells. Infect Immun 75, 4334-4341. Blois, S.M., Ilarregui, J.M., Tometten, M., Garcia, M., Orsal, A.S., Cordo-Russo, R., Toscano, M.A., Bianco, G.A., Kobelt, P., Handjiski, B., et al. (2007). A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13, 1450-1457. Bour-Jordan, H., and Bluestone, J.A. (2009). Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 229, 41-66. Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B., Yasayko, S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F., and Ramsdell, F. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27, 68-73. Burmeister, Y., Lischke, T., Dahler, A.C., Mages, H.W., Lam, K.P., Coyle, A.J., Kroczek, R.A., and Hutloff, A. (2008). ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol 180, 774-782. Butte, M.J., Keir, M.E., Phamduy, T.B., Sharpe, A.H., and Freeman, G.J. (2007). Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27, 111-122. Catalfamo, M., Tai, X., Karpova, T., McNally, J., and Henkart, P.A. (2008). TcR-induced regulated secretion leads to surface expression of CTLA-4 in CD4(+)CD25(+) T cells. Immunology. Coombes, J.L., Siddiqui, K.R., Arancibia-Carcamo, C.V., Hall, J., Sun, C.M., Belkaid, Y., and Powrie, F. (2007). A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204, 1757-1764. Cooper, D.N. (2002). Galectinomics: finding themes in complexity. Biochim Biophys Acta 1572, 209-231. Craig, S.S., Krishnaswamy, P., Irani, A.M., Kepley, C.L., Liu, F.T., and Schwartz, L.B. (1995). Immunoelectron microscopic localization of galectin-3, an IgE binding protein, in human mast cells and basophils. Anat Rec 242, 211-219. Das, S., Su--arez, G., Beswick, E.J., Sierra, J.C., Graham, D.Y., and Reyes, V.E. (2006). Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol 176, 3000-3009. Demetriou, M., Granovsky, M., Quaggin, S., and Dennis, J.W. (2001). Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733-739. Dietz, A.B., Bulur, P.A., Knutson, G.J., Matasic, R., and Vuk-Pavlovic, S. (2000). Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem Biophys Res Commun 275, 731-738. Drickamer, K., and Taylor, M.E. (1993). Biology of animal lectins. Annu Rev Cell Biol 9, 237-264. Dumic, J., Dabelic, S., and Flogel, M. (2006). Galectin-3: an open-ended story. Biochim Biophys Acta 1760, 616-635. Fife, B.T., and Bluestone, J.A. (2008). Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224, 166-182. Flotte, T.J., Springer, T.A., and Thorbecke, G.J. (1983). Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am J Pathol 111, 112-124. Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330-336. Frigeri, L.G., and Liu, F.T. (1992). Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol 148, 861-867. Frigeri, L.G., Zuberi, R.I., and Liu, F.T. (1993). Epsilon BP, a beta-galactoside-binding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells. Biochemistry 32, 7644-7649. Fukumori, T., Takenaka, Y., Yoshii, T., Kim, H.R., Hogan, V., Inohara, H., Kagawa, S., and Raz, A. (2003). CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 63, 8302-8311. Garin, M.I., Chu, C.C., Golshayan, D., Cernuda-Morollon, E., Wait, R., and Lechler, R.I. (2007). Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 109, 2058-2065. Gong, H.C., Honjo, Y., Nangia-Makker, P., Hogan, V., Mazurak, N., Bresalier, R.S., and Raz, A. (1999). The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res 59, 6239-6245. Green, E.A., Gorelik, L., McGregor, C.M., Tran, E.H., and Flavell, R.A. (2003). CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci U S A 100, 10878-10883. Henson, S.M., Macaulay, R., Kiani-Alikhan, S., and Akbar, A.N. (2008). The use of the inhibitory receptors for modulating the immune responses. Curr Pharm Des 14, 2643-2650. Hirabayashi, J., Hashidate, T., Arata, Y., Nishi, N., Nakamura, T., Hirashima, M., Urashima, T., Oka, T., Futai, M., Muller, W.E., et al. (2002). Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572, 232-254. Hirabayashi, J., and Kasai, K. (1993). The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology 3, 297-304. Ho, M.K., and Springer, T.A. (1982). Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J Immunol 128, 1221-1228. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061. Houzelstein, D., Goncalves, I.R., Fadden, A.J., Sidhu, S.S., Cooper, D.N., Drickamer, K., Leffler, H., and Poirier, F. (2004). Phylogenetic analysis of the vertebrate galectin family. Mol Biol Evol 21, 1177-1187. Hsu, D.K., Hammes, S.R., Kuwabara, I., Greene, W.C., and Liu, F.T. (1996). Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3. Am J Pathol 148, 1661-1670. Hsu, D.K., Zuberi, R.I., and Liu, F.T. (1992). Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin. J Biol Chem 267, 14167-14174. Huber, S., Schramm, C., Lehr, H.A., Mann, A., Schmitt, S., Becker, C., Protschka, M., Galle, P.R., Neurath, M.F., and Blessing, M. (2004). Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173, 6526-6531. Hubert, M., Wang, S.Y., Wang, J.L., Seve, A.P., and Hubert, J. (1995). Intranuclear distribution of galectin-3 in mouse 3T3 fibroblasts: comparative analyses by immunofluorescence and immunoelectron microscopy. Exp Cell Res 220, 397-406. Ito, T., Hanabuchi, S., Wang, Y.H., Park, W.R., Arima, K., Bover, L., Qin, F.X., Gilliet, M., and Liu, Y.J. (2008). Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28, 870-880. Iurisci, I., Tinari, N., Natoli, C., Angelucci, D., Cianchetti, E., and Iacobelli, S. (2000). Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res 6, 1389-1393. Karlsson, A., Follin, P., Leffler, H., and Dahlgren, C. (1998). Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood 91, 3430-3438. Kasper, M., and Hughes, R.C. (1996). Immunocytochemical evidence for a modulation of galectin 3 (Mac-2), a carbohydrate binding protein, in pulmonary fibrosis. J Pathol 179, 309-316. Kemper, C., Chan, A.C., Green, J.M., Brett, K.A., Murphy, K.M., and Atkinson, J.P. (2003). Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388-392. Kolar, P., Knieke, K., Hegel, J.K., Quandt, D., Burmester, G.R., Hoff, H., and Brunner-Weinzierl, M.C. (2009). CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum 60, 123-132. Kubach, J., Lutter, P., Bopp, T., Stoll, S., Becker, C., Huter, E., Richter, C., Weingarten, P., Warger, T., Knop, J., et al. (2007). Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 110, 1550-1558. Kuwabara, I., and Liu, F.T. (1996). Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 156, 3939-3944. Leffler, H., Carlsson, S., Hedlund, M., Qian, Y., and Poirier, F. (2004). Introduction to galectins. Glycoconj J 19, 433-440. Lippert, E., Gunckel, M., Brenmoehl, J., Bataille, F., Falk, W., Scholmerich, J., Obermeier, F., and Rogler, G. (2008). Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation. Clin Exp Immunol 152, 285-297. Liu, F.T. (2000). Galectins: a new family of regulators of inflammation. Clin Immunol 97, 79-88. Liu, Y., Zeng, B., Zhang, Z., Zhang, Y., and Yang, R. (2008). B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. Clin Immunol 129, 471-481. Maeda, N., Kawada, N., Seki, S., Arakawa, T., Ikeda, K., Iwao, H., Okuyama, H., Hirabayashi, J., Kasai, K., and Yoshizato, K. (2003). Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways. J Biol Chem 278, 18938-18944. Martins, G.A., Cimmino, L., Shapiro-Shelef, M., Szabolcs, M., Herron, A., Magnusdottir, E., and Calame, K. (2006). Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol 7, 457-465. Mehul, B., Bawumia, S., Martin, S.R., and Hughes, R.C. (1994). Structure of baby hamster kidney carbohydrate-binding protein CBP30, an S-type animal lectin. J Biol Chem 269, 18250-18258. Mills, K.H. (2004). Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4, 841-855. Miyamoto, K., Kingsley, C.I., Zhang, X., Jabs, C., Izikson, L., Sobel, R.A., Weiner, H.L., Kuchroo, V.K., and Sharpe, A.H. (2005). The ICOS molecule plays a crucial role in the development of mucosal tolerance. J Immunol 175, 7341-7347. Moutsatsos, I.K., Davis, J.M., and Wang, J.L. (1986). Endogenous lectins from cultured cells: subcellular localization of carbohydrate-binding protein 35 in 3T3 fibroblasts. J Cell Biol 102, 477-483. Moutsatsos, I.K., Wade, M., Schindler, M., and Wang, J.L. (1987). Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proc Natl Acad Sci U S A 84, 6452-6456. Muller, S., Schaffer, T., Flogerzi, B., Fleetwood, A., Weimann, R., Schoepfer, A.M., and Seibold, F. (2006). Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD. Inflamm Bowel Dis 12, 588-597. Raimond, J., Zimonjic, D.B., Mignon, C., Mattei, M., Popescu, N.C., Monsigny, M., and Legrand, A. (1997). Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22. Mamm Genome 8, 706-707. Razmara, M., Hilliard, B., Ziarani, A.K., Chen, Y.H., and Tykocinski, M.L. (2008). CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells. Int Immunol 20, 471-483. Read, S., Greenwald, R., Izcue, A., Robinson, N., Mandelbrot, D., Francisco, L., Sharpe, A.H., and Powrie, F. (2006). Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol 177, 4376-4383. Saada, A., Reichert, F., and Rotshenker, S. (1996). Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol 133, 159-167. Salomon, B., Lenschow, D.J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., and Bluestone, J.A. (2000). B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440. Sano, H., Hsu, D.K., Apgar, J.R., Yu, L., Sharma, B.B., Kuwabara, I., Izui, S., and Liu, F.T. (2003). Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 112, 389-397. Sato, S., and Hughes, R.C. (1994). Control of Mac-2 surface expression on murine macrophage cell lines. Eur J Immunol 24, 216-221. Sato, S., and Hughes, R.C. (1994). Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J Biol Chem 269, 4424-4430. Seki, M., Oomizu, S., Sakata, K.M., Sakata, A., Arikawa, T., Watanabe, K., Ito, K., Takeshita, K., Niki, T., Saita, N., et al. (2008). Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127, 78-88. Sharpe, A.H., Wherry, E.J., Ahmed, R., and Freeman, G.J. (2007). The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8, 239-245. Smetana, K., Holikova, Z., Klubal, R., Bovin, N.V., Dvorankova, B., Bartunkova, J., Liu, F.T., and Gabius, H.J. (1999). Coexpression of binding sites for A(B) histo-blood group trisaccharides with galectin-3 and Lag antigen in human Langerhans cells. J Leukoc Biol 66, 644-649. Stillman, B.N., Hsu, D.K., Pang, M., Brewer, C.F., Johnson, P., Liu, F.T., and Baum, L.G. (2006). Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176, 778-789. Toscano, M.A., Commodaro, A.G., Ilarregui, J.M., Bianco, G.A., Liberman, A., Serra, H.M., Hirabayashi, J., Rizzo, L.V., and Rabinovich, G.A. (2006). Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J Immunol 176, 6323-6332. Tran, D.Q., Ramsey, H., and Shevach, E.M. (2007). Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110, 2983-2990. Truong, M.J., Gruart, V., Kusnierz, J.P., Papin, J.P., Loiseau, S., Capron, A., and Capron, M. (1993). Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac-2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation. J Exp Med 177, 243-248. Truong, M.J., Gruart, V., Liu, F.T., Prin, L., Capron, A., and Capron, M. (1993). IgE-binding molecules (Mac-2/epsilon BP) expressed by human eosinophils. Implication in IgE-dependent eosinophil cytotoxicity. Eur J Immunol 23, 3230-3235. van der Leij, J., van den Berg, A., Blokzijl, T., Harms, G., van Goor, H., Zwiers, P., van Weeghel, R., Poppema, S., and Visser, L. (2004). Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response. J Pathol 204, 511-518. Vignali, D.A., Collison, L.W., and Workman, C.J. (2008). How regulatory T cells work. Nat Rev Immunol 8, 523-532. Wang, L., Pino-Lagos, K., de Vries, V.C., Guleria, I., Sayegh, M.H., and Noelle, R.J. (2008). Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc Natl Acad Sci U S A 105, 9331-9336. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., and Sakaguchi, S. (2008). CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271-275. Wollenberg, A., de la Salle, H., Hanau, D., Liu, F.T., and Bieber, T. (1993). Human keratinocytes release the endogenous beta-galactoside-binding soluble lectin immunoglobulin E (IgE-binding protein) which binds to Langerhans cells where it modulates their binding capacity for IgE glycoforms. J Exp Med 178, 777-785. Yu, F., Finley, R.L., Jr., Raz, A., and Kim, H.R. (2002). Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem 277, 15819-15827. Zhu, C., Anderson, A.C., Schubart, A., Xiong, H., Imitola, J., Khoury, S.J., Zheng, X.X., Strom, T.B., and Kuchroo, V.K. (2005). The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6, 1245-1252. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42635 | - |
dc.description.abstract | Galectin-3 是一個分子量為31kDa的蛋白質,屬於哺乳類-半乳糖苷結合蛋白質家族(galectin family)的一員。它表現在細胞核或是細胞質之中,或是以非典型的方式分泌到細胞外;同時它也被認為和自體免疫疾病中產生的發炎反應有所關聯。先前的研究報告中指出部份galectin家族的成員可以藉由影響調節性T細胞的功能進而抑制自體免疫疾病的發生。然而galectin-3在T細胞的調節功能中所扮演的角色還尚未清楚。為了進一步釐清這個問題,我們試圖去了解在試管以及活體的環境之下,galectin-3是否能夠誘發調節性T細胞。我們想要了解galectin-3在誘發調節性T細胞的過程中所扮演的角色,因此在加入galectin-3以後,觀察T細胞在免疫特徵上的變化以及T細胞所表現的轉錄因子。我們同時在動物實驗中研究galectin-3誘發出調節性T細胞以後對於免疫反應及疾病發生的影響。我們利用流式細胞儀分析的結果發現在人類T細胞株(Jurkat cell)或是初級T細胞中,galectin-3可以誘發PD-1以及CTLA-4的表現。除此之外,在加入galectin-3以後也可以使的CD4 T細胞中的轉錄因子FoxP3表現增加;同時也增加了細胞激素TGF-β的產量。這些結果說明了在試管的環境之下,galectin-3的確可以誘發調節性T細胞,並且也使的調節性T細胞中TGF-β的產量上升;然而在加入乳糖以後,這些現象都會因為galectin-3和乳糖結合使得galectin-3被阻擋而無法和表現在T細胞表面的配位基結合而消失。同時在動物實驗中,我們利用腹腔注射galectin-3到小鼠體內以後,分析小鼠的脾臟細胞發現調節性T細胞也會上升。並且在右旋葡聚糖硫酸鈉誘導的小鼠結腸炎中發現galectin-3可以降低小鼠體重下降以及腸道發炎的程度。綜合以上實驗結果,我們發現galectin-3可以誘發調節性T細胞,並且在腸道發炎的小鼠模式中具有保護的效果。因此我們認為galectin-3能夠藉由誘發調節性T細胞來達到治療的效果,在臨床上具有治療及調控免疫反應的潛力。 | zh_TW |
dc.description.abstract | Galectin-3 is a 31kDa protein, which belong to a family of mammalian b-galactoside-binding proteins. Galectin-3 is present intracellularly within nucleus and cytoplasm or secreted via non-classical pathway outside of cell; and it also has been implicated in the inflammatory immune response in autoimmune diseases. Previous studies demonstrated that several members of galectin family are able to suppress the autoimmune disease via mediating the function of Treg cells. However, the role of galectin-3 mediating the regulatory function in T cells is remained to be further elucidated. In order to address this issue, we attempt to investigate whether galectin-3 induces the Tregs in vitro and in vivo. We examine the immuno phenotype and expression of the transcription factor in T cells after administration of galectin-3. We also investigate the suppressive function of Treg cells induced by galectin-3 in immune response in vivo. Our results demonstrated that galectin-3 induce the expression of PD-1 and CTLA-4 on both Jurkat cells and human primary T cells. In addition, the expression of FoxP3 is up-regulated in CD4 T cells and the frequency of CD4+FoxP3+TGF-β+ T cell is higher in response to galectin-3 according to flow cytometry analysis. These finding indicate that galectin-3 induce the generation of FoxP3+ T cells and increase the production of TGF-β in vitro, while induction of FoxP3+ T cells is abolished by adding lactose to block the interaction between galectin-3 and its ligands on T cells. Furthermore, treatment with recombinant galectin-3 induced the FoxP3+ T cells and ameliorated the severity of DSS-induced Inflammatory Bowel Disease (IBD). In conclusion, our finding demonstrates that galectin-3 induces Tregs and ameliorates the severity of DSS-induced colitis. It suggests that galectin-3 is potential for therapeutic immuno modulation via induction of Tregs. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T01:18:20Z (GMT). No. of bitstreams: 1 ntu-98-R96449001-1.pdf: 692590 bytes, checksum: a2343aaeca4b505908d61f0d6141f08f (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 誌謝 i
中文摘要 ii Abstract iii Chapter I Introduction 1 Part A Structural characteristic of galectin-3 1 Part B Cell distribution of galectin-3 2 Part C Galectin-3 in immune response 3 Part D The role of galectins in regulatory T cells 4 Part E Regulatory T cells 5 Part F The role of co-stimulatory molecule in regulatory T cells 6 Chapter II Aims and motivation of the study 8 Motivation 8 Aims 9 Chapter III Materials and methods 10 Materials 10 1 Cell Lines 10 2 Antibodies 10 3 Chemicals and reagents 11 4 Buffer 14 Methods 15 1 Animals 15 2 Culture of human T cell line, Jurkat cells 15 3 Purification of recombinant human galectin-3 15 4 Isolation of human T cells 16 5 Flow cytometry analysis 17 6 DSS induced colitis 18 7 Statistical analysis 19 Chapter IV Results 20 Part A Galectin-3 increase the expression of PD-1 and CTLA-4 on human primary T cells 20 Part B Galectin-3 induces PD-1 expression in CD4 and CD8 T cells 21 Part C Galectin-3 induces the expression of FoxP3 in human primary T cells 22 Part D Galectin-3 increases the production of inhibitory cytokine TGF-β in human CD4+FoxP3+ T cells 23 Part E Galectin-3 increases the population of CD4+FOXP3+ T cells in vivo and ameliorates the severity of DSS-induced colitis 24 Chapter V Discussions 26 Part A Effects of galectin-3 on expression of co-stimulatory molecules 26 Part B The possible mechanism of galectin-3 induce the regulatory T cells 27 Part C The character of galectin-3 induced Tregs 28 Part D Conclusion 29 References 31 Figure 1 Galectin-3 enhance the expression of PD-1 on human primary T cells in a dose dependant manner 45 Figure 2 Galectin-3 enhance the expression of CTLA-4 on human primary T cells 47 Figure 3 In response to galectin-3, the number of CD4+PD-1+T cell is higher than CD8+PD-1+ T cell 49 Figure 4 The population of CD4+CD25+PD-1+ T cells increases while human primary T cells are treated with galectin-3 50 Figure 5 Galectin-3 induce the population of human CD4+FoxP3+ T cells 54 Figure 6 Galectin-3 increase the production of TGF-β in CD4+FoxP3+ T cells 56 Figure 7 Galectin-3 promote the expression of co-stimulatory molecules on CD4+FoxP3+ T cells 57 Figure 8 Galectin-3 induces the CD4+FoxP3+ T cells in vivo 59 Figure 9 The development of DSS induced inflammantory bowel disease is suppressed in mice injecting with galectin-3 61 | |
dc.language.iso | en | |
dc.title | Galectin-3誘發調節性T細胞之研究 | zh_TW |
dc.title | Galectin-3 in induction of regulatory T cell | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 司徒惠康,陳俊任 | |
dc.subject.keyword | 調節性T細胞,Galectin-3, | zh_TW |
dc.subject.keyword | Galectin-3,FoxP3,PD-1,CTLA-4,DSS, | en |
dc.relation.page | 61 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-07-27 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 免疫學研究所 | zh_TW |
顯示於系所單位: | 免疫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 676.36 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。